NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)
Agency: National Institutes of Health
Assistance Listings: 93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders
Description
(Reissue of PAR-21-266) The purpose of this funding opportunity announcement (FOA) is to provide a vehicle for Small Business Concerns (SBCs) submitting Small Business Innovation Research (SBIR) grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The projects must focus on products related to the mission and goals of the NINDS and may evaluate drugs, biologics, devices, or diagnostics, as well as surgical, behavioral or rehabilitation therapies. Only SBIR Phase II and Fast-Track applications are supported under this program. SBIR Phase I applications are only accepted as part of a Fast-track application.
Eligibility
Eligible applicants
Business
- Small businesses
Additional information
Grantor contact information
Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Documents
No documents are currently available.
Link to additional information
https://grants.nih.gov/grants/guide/pa-files/PAR-23-311.html
Archived: November 18, 2025
Award
$--
Program Funding
--
Expected awards
$--
Award Minimum
$--
Award Maximum
Funding opportunity number:
PAR-23-311
Cost sharing or matching requirement:
Funding instrument type:
Grant
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Health
Category Explanation:
History
Version:
2
Posted date:
November 27, 2023
Archive date:
November 18, 2025
